Cooper C. Collins, Director at TherapeuticsMD, Inc. (TXMD), bought 1,000,000 shares at $0.77 ($725K) on 2021-08-17, disclosed to the SEC on 2021-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.77 | 100,000 | $77K | 10.6% |
| 2 | $0.72 | 900,000 | $648K | 89.4% |
| Total | $0.72 avg | 1,000,000 | $725K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |
| TXMD | BUY | 2019-05-15 | $100K | — | Filing → |